Li XY - Search Results

1

Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses.

Jabbour A, Hayward CS, Keogh AM, Kotlyar E, McCrohon JA, England JF, Amor R, Liu X, Li XY, Zhou MD, Graham RM, Macdonald PS. Jabbour A, et al. Among authors: li xy. Eur J Heart Fail. 2011 Jan;13(1):83-92. doi: 10.1093/eurjhf/hfq152. Epub 2010 Sep 1. Eur J Heart Fail. 2011. PMID: 20810473 Free article. Clinical Trial.

2

Neuregulin-1/ErbB signaling and chronic heart failure.

Xu Y, Li X, Liu X, Zhou M. Xu Y, et al. Adv Pharmacol. 2010;59:31-51. doi: 10.1016/S1054-3589(10)59002-1. Adv Pharmacol. 2010. PMID: 20933198 Review.

3

A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure.

Gao R, Zhang J, Cheng L, Wu X, Dong W, Yang X, Li T, Liu X, Xu Y, Li X, Zhou M. Gao R, et al. J Am Coll Cardiol. 2010 May 4;55(18):1907-14. doi: 10.1016/j.jacc.2009.12.044. J Am Coll Cardiol. 2010. PMID: 20430261 Free article. Clinical Trial.

4

Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy.

Liu X, Gu X, Li Z, Li X, Li H, Chang J, Chen P, Jin J, Xi B, Chen D, Lai D, Graham RM, Zhou M. Liu X, et al. J Am Coll Cardiol. 2006 Oct 3;48(7):1438-47. doi: 10.1016/j.jacc.2006.05.057. Epub 2006 Sep 14. J Am Coll Cardiol. 2006. PMID: 17010808 Free article.

5

Cardiac functional improvement in rats with myocardial infarction by up-regulating cardiac myosin light chain kinase with neuregulin.

Gu X, Liu X, Xu D, Li X, Yan M, Qi Y, Yan W, Wang W, Pan J, Xu Y, Xi B, Cheng L, Jia J, Wang K, Ge J, Zhou M. Gu X, et al. Cardiovasc Res. 2010 Nov 1;88(2):334-43. doi: 10.1093/cvr/cvq223. Epub 2010 Jul 8. Cardiovasc Res. 2010. PMID: 20615916

6

Neuregulin-1 preconditioning protects the heart against ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.

Fang SJ, Wu XS, Han ZH, Zhang XX, Wang CM, Li XY, Lu LQ, Zhang JL. Fang SJ, et al. Among authors: li xy. Chin Med J (Engl). 2010 Dec;123(24):3597-604. Chin Med J (Engl). 2010. PMID: 22166638

7

Neuregulin-1/ErbB signaling: a druggable target for treating heart failure.

Xu Y, Li X, Zhou M. Xu Y, et al. Curr Opin Pharmacol. 2009 Apr;9(2):214-9. doi: 10.1016/j.coph.2008.11.004. Epub 2008 Dec 11. Curr Opin Pharmacol. 2009. PMID: 19070544 Review.

8

Neuregulin 1 treatment improves glucose tolerance in diabetic db/db mice, but not in healthy mice.

Ennequin G, Caillaud K, Chavanelle V, Teixeira A, Etienne M, Li X, Boisseau N, Sirvent P. Ennequin G, et al. Arch Physiol Biochem. 2020 Oct;126(4):320-325. doi: 10.1080/13813455.2018.1534243. Epub 2018 Nov 17. Arch Physiol Biochem. 2020. PMID: 30449185

9

[Metabolomics combined with bioinformatics reveals mechanism of Sanhuang Hushen Fangshuai Decoction in treating chronic kidney disease].

Zhang CH, Li XY, Zheng HX, Zhao M, Zhu MF, Min SQ, Zhang XY, Wang SJ. Zhang CH, et al. Among authors: li xy. Zhongguo Zhong Yao Za Zhi. 2024 Dec;49(23):6468-6480. doi: 10.19540/j.cnki.cjcmm.20240912.501. Zhongguo Zhong Yao Za Zhi. 2024. PMID: 39805793 Chinese.

10

[Mini-barcode combined with ITS2 for identification of bulk Artemisiae Scopariae Herba].

Li XY, Guo H, Ma MX, Xu LW, Huang YH, Zhang Y, Yang CP, He F, Tian XX. Li XY, et al. Zhongguo Zhong Yao Za Zhi. 2024 Dec;49(24):6685-6691. doi: 10.19540/j.cnki.cjcmm.20240912.101. Zhongguo Zhong Yao Za Zhi. 2024. PMID: 39805757 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,786 results

Search Page

Filters